Variables | Surgery | P-value | |||
---|---|---|---|---|---|
BCT | Mastectomy | ||||
N | Percentage (%) | N | Percentage (%) | ||
N | 748 | 100 | 422 | 100 | |
Age | < 0.001 | ||||
< 40 | 24 | 3.21 | 29 | 6.87 | |
40–49 | 91 | 12.17 | 83 | 19.67 | |
50–59 | 216 | 28.88 | 126 | 29.86 | |
60–69 | 223 | 29.81 | 114 | 27.01 | |
≥ 70 | 194 | 25.94 | 70 | 16.59 | |
Mean (± SD) | 61.16 ± 11.35 | 57.65 ± 11.72 | < 0.001* | ||
Race | 0.14** | ||||
White | 587 | 78.48 | 340 | 80.57 | |
Black | 92 | 12.30 | 45 | 10.66 | |
Asian or Pacific Islander | 57 | 7.62 | 36 | 8.53 | |
American Indian/Alaska Native | 9 | 1.20 | 0 | 0 | |
Unknown/other | 3 | 0.40 | 1 | 0.24 | |
Marital status | 0.64 | ||||
Not married | 289 | 34.17 | 153 | 36.3 | |
Married | 433 | 61.67 | 256 | 60.7 | |
Unknown | 26 | 4.17 | 13 | 3.1 | |
Grade | 0.30 | ||||
I/II | 35 | 4.68 | 28 | 6.64 | |
III | 135 | 18.05 | 85 | 20.14 | |
IV | 7 | 0.94 | 2 | 0.47 | |
Unknown | 571 | 76.34 | 307 | 72.75 | |
Laterality | 0.15 | ||||
Right | 342 | 45.72 | 212 | 50.24 | |
Left | 406 | 54.28 | 210 | 49.76 | |
Histology | 0.04 | ||||
Ductal carcinoma | 277 | 37.03 | 192 | 45.50 | |
Lobular carcinoma | 37 | 4.95 | 16 | 3.79 | |
Mixed type | 16 | 2.14 | 9 | 2.13 | |
Other | 418 | 55.88 | 205 | 48.58 | |
N | < 0.001 | ||||
N1mi | 12 | 1.60 | 19 | 4.50 | |
N1 | 481 | 64.30 | 226 | 53.55 | |
N2 | 131 | 17.51 | 95 | 22.51 | |
N3 | 124 | 16.58 | 82 | 19.43 | |
No. of examined LN | < 0.001 | ||||
1–3 | 131 | 17.51 | 49 | 11.61 | |
4–9 | 100 | 13.37 | 72 | 17.06 | |
≥ 10 | 390 | 52.14 | 276 | 65.40 | |
Other/Unknown | 127 | 16.98 | 25 | 5.92 | |
No. of positive LN | < 0.001 | ||||
1–3 | 376 | 50.27 | 227 | 53.79 | |
4–9 | 117 | 15.64 | 93 | 22.04 | |
≥ 10 | 86 | 11.50 | 60 | 14.22 | |
Other/Unknown | 169 | 22.59 | 42 | 9.95 | |
Stage | < 0.001 | ||||
IB | 12 | 1.60 | 19 | 4.50 | |
IIA | 481 | 64.30 | 226 | 53.55 | |
IIIA | 131 | 17.51 | 96 | 22.75 | |
IIIC | 124 | 16.58 | 81 | 19.19 | |
Radiation | < 0.001 | ||||
Yes | 462 | 61.76 | 215 | 50.95 | |
None/Unknown | 286 | 38.24 | 207 | 49.05 | |
Chemotherapy | 0.003 | ||||
Yes | 566 | 75.67 | 351 | 83.18 | |
No/Unknown | 182 | 24.33 | 71 | 16.82 | |
Type of systemic therapy | < 0.001 | ||||
Neoadjuvant | 61 | 8.16 | 55 | 13.03 | |
Adjuvant | 380 | 50.80 | 196 | 46.45 | |
Neoadjuvant + adjuvant | 49 | 6.55 | 54 | 12.80 | |
Only systemic therapy, no surgery | 28 | 3.74 | 0 | 0 | |
Other | 113 | 15.11 | 74 | 17.54 | |
No/Unknown | 117 | 15.64 | 43 | 10.19 | |
Subtypes | 0.48 | ||||
Luminal A | 214 | 28.61 | 106 | 25.12 | |
Luminal B | 65 | 8.69 | 44 | 10.43 | |
HER2 + | 51 | 6.82 | 23 | 5.45 | |
Triple negative | 93 | 12.43 | 52 | 12.32 | |
Unknown | 325 | 43.45 | 197 | 46.68 | |
ER | 0.89 | ||||
Negative | 259 | 34.63 | 149 | 35.31 | |
Borderline/Unknown | 61 | 8.16 | 37 | 8.77 | |
Positive | 428 | 57.22 | 236 | 55.92 | |
PR | 0.76 | ||||
Negative | 372 | 49.73 | 215 | 50.95 | |
Borderline/Unknown | 77 | 10.29 | 47 | 11.14 | |
Positive | 299 | 39.97 | 160 | 37.91 | |
HER2 | 0.44 | ||||
Negative | 307 | 41.04 | 158 | 37.44 | |
Positive | 118 | 15.78 | 67 | 15.88 | |
Unknown | 323 | 43.18 | 197 | 46.68 |